Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| (NYSE: CYBN) | Delayed: 8.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.28 | 52 Week High | $ | |||
| Open | $8.28 | 52 Week Low | $ | |||
| Day High | $8.28 | P/E | N/A | |||
| Day Low | $8.28 | EPS | $ | |||
| Volume | 10 | |||||
| (NYSE: CYBN) | Delayed: 8.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.28 | 52 Week High | $ | |||
| Open | $8.28 | 52 Week Low | $ | |||
| Day High | $8.28 | P/E | N/A | |||
| Day Low | $8.28 | EPS | $ | |||
| Volume | 10 | |||||
